FDA expands marketing of 23andMe to include medication metabolism
Healio The FDA expanded the marketing of the 23andMe Personal Genome Service Pharmacogenetic Reports test to provide information about 33 genetic variants that may be linked with a patient's ability to metabolize some medications to help inform discussions ... |
November 01, 2018 at 01:19PM | marketing - Google News
FDA expands marketing of 23andMe to include medication metabolism - Healio
marketing - Google News
Nenhum comentário:
Postar um comentário